-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
At the provincial video conference on safe production of hazardous chemicals, Shisi Pharmaceutical delivered a model speech.
Category:
Time：2020-03-18
On the afternoon of March 16, the Hebei Provincial Department of Emergency Management convened a video dispatch meeting on safe production of hazardous chemicals across the province.
On the afternoon of March 16, the Hebei Provincial Department of Emergency Management convened a video dispatch meeting on safe production of hazardous chemicals across the province. Officials from the emergency management bureaus of all cities in the province, as well as senior executives from hazardous chemical and pharmaceutical enterprises throughout the province, attended the video conference. In total, more than 3,000 people participated in the main venue and sub-venues. Wu Hengyao, General Manager of Shijiazhuang Sihua Pharmaceutical Co., Ltd., delivered a keynote speech.
Wu Hengyao, General Manager of Shijiazhuang Sihua Pharmaceutical Co., Ltd., delivered a keynote speech.
The meeting interpreted the “Opinions Issued by the General Office of the CPC Central Committee and the General Office of the State Council on Comprehensively Strengthening Safety Production of Hazardous Chemicals,” and made arrangements for relevant work to prevent production safety accidents in chemical enterprises during the recent period of epidemic prevention and control and intensive resumption of work and production.
The meeting emphasized that we are currently at a critical stage in both epidemic prevention and control as well as resuming work and production. Therefore, ensuring safe production during the resumption of work and production is particularly important. Enterprises must earnestly assume their primary responsibility and strictly implement safety measures on the premise that epidemic prevention and control measures are fully in place. All localities and departments must attach great importance to this task, establish enforcement and inspection teams at the provincial, municipal, and county levels, and carry out “full-coverage” special inspections through on-site inspections, remote monitoring, and online surveillance. We must resolutely eliminate potential risks and hazards and firmly uphold the bottom line of safe production.
The meeting called for strengthening the responsibility system for work safety among leading cadres at all levels, consistently and steadfastly focusing on preventing and controlling major safety risks. It emphasized the need to enhance data analysis and in-depth examination of typical cases, truly gaining a clear understanding of the situation, pinpointing problems accurately, identifying appropriate countermeasures, and earnestly shouldering the political and legal responsibilities for preventing and controlling major safety risks. We must rigorously implement the “three musts” regarding departmental regulatory responsibilities, draw on beneficial practices from some localities in innovating safety supervision and safety services, and make greater efforts in precision enforcement and precision service delivery. We should thoroughly identify and address major safety hazards and strengthen preventive measures and risk mitigation efforts. It is essential to strictly enforce safety measures for resuming work and production, adopt differentiated safety supervision based on regional and industry-specific classifications, and urge enterprises to earnestly assume their primary responsibilities. We should combine positive incentives with negative sanctions, and firmly uphold the safety bottom line.
Wu Hengyao, General Manager of Shijiazhuang Sihua Pharmaceutical Co., Ltd., delivered a keynote speech.
At the meeting, three companies—including Shijiazhuang No.4 Pharmaceutical Co., Ltd.—delivered keynote speeches on how to ensure safe production during the epidemic prevention and control period.
During his speech, Wu Hengyao, General Manager of Shijiazhuang No.4 Pharmaceutical, stated that since the outbreak of the epidemic, Shijiazhuang No.4 Pharmaceutical has always put the safety and health of the people first. In accordance with the work arrangements of the provincial Party committee and provincial government as well as the municipal Party committee and municipal government, and under the guidance of emergency management departments at all levels, the company has made every effort to ensure the production and supply of pharmaceuticals for epidemic prevention and control. The implementation of epidemic prevention measures has been taken as a prerequisite for ensuring safe production during this special period. The company has continuously improved its emergency plans for safe production during the epidemic, innovatively conducted safety training, and ensured that all emergency response personnel remain fully on duty at all times. As a result, safety supervision during the epidemic has never been neglected, and key tasks have never been relaxed. At the same time, the company has made full use of modern information technologies—such as video live streaming, internet platforms, and WeChat official accounts—to carry out employee safety training. The training has focused on essential safety knowledge, job-specific safety operating procedures, safety risk management and hazard identification/disposal, as well as personal labor protection measures, thereby achieving both effective epidemic prevention and safe production without compromise.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license